Aplastic Anemia Virtual Support Group - 2022 October
Event Date:
Thu, 10/06/2022 - 4:00pm (EDT)
AAMDSIF is pleased to announce that we will host a support group for patients diagnosed with
Bone Marrow Disease(s):
IMPORTANT: UPDATED Guidance for Patients on COVID-19 including Vaccine Information»
AAMDSIF is pleased to announce that we will host a support group for patients diagnosed with
AAMDSIF is pleased to announce that we will host a support group for patients diagnosed with
AAMDSIF is pleased to announce that we will host a support group for patients diagnosed with
Carlo Dufour works in G.Gaslini Research Children’s Hospital, Genova, Italy, the largest, multi specialist pediatric hospital of the country, where he chairs the Hemo-Onco- HSCT Department and the Hematology Unit where have seat the national Registry of
BOSTON--(BUSINESS WIRE)--Aug. 1, 2022-- Gamida Cell Ltd. (Nasdaq: GMDA), the leader in the development of NAM-enabled cell therapy candidates for patients with hematologic and solid cancers and other serious diseases, announced today that the U.S. Food and Drug Administration (FDA) has accepted for filing the Company’s Biologics License Application (BLA) for omidubicel for the treatment of patients with blood cancers in need of an allogenic hematopoietic stem cell transplant.
Find the recordings for the 2022 Memphis Patient and Family Hybrid Conference here:
In this conference session, Dr. Sharma discusses what causes severe
In this conference session, Dr. Wlodarski discusses the basics of Pediatric MDS, the differences between MDS in children and adults, and practical examples on GATA2 and SAMD9/9L.
In this two-part conference session, Dr. Brion Randolph discusses the process of transplant as a modality for treating
